Tower Research Capital LLC (Trc) Sio Gene Therapies Inc. Transaction History

Tower Research Capital LLC (Trc)

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$0.28 - $0.44 $6,398 - $10,055	-22,853 Reduced 59.66%	15,453 $7,000
Q3 2022 Nov 10, 2022	BUY	$0.28 - $0.41 $921 - $1,349	3,292 Added 9.4%	38,306 $11,000
Q2 2022 Aug 15, 2022	BUY	$0.25 - $0.73 $6,688 - $19,528	26,752 Added 323.8%	35,014 $13,000
Q1 2022 May 12, 2022	SELL	$0.55 - $1.47 $2,096 - $5,602	-3,811 Reduced 31.57%	8,262 $6,000
Q4 2021 Feb 14, 2022	BUY	$1.29 - $2.36 $3,626 - $6,633	2,811 Added 30.35%	12,073 $16,000
Q3 2021 Nov 15, 2021	BUY	$1.81 - $2.7 $16,581 - $24,734	9,161 Added 9070.3%	9,262 $20,000
Q2 2021 Aug 16, 2021	SELL	$2.07 - $2.89 $8,234 - $11,496	-3,978 Reduced 97.52%	101 $0
Q1 2021 May 17, 2021	SELL	$2.34 - $3.44 $33,291 - $48,940	-14,227 Reduced 77.72%	4,079 $11,000
Q4 2020 Feb 16, 2021	BUY	$1.91 - $5.63 $34,964 - $103,062	18,306 New	18,306 $51,000

147K

Ticker SIOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,975,200
Description
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.